Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Venous Thrombosis

Free Subscription Articles published in Thromb Res Retrieve available abstracts of 257 articles: HTML format

Single Articles

November 2021
1. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
   Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
   Thromb Res. 2021;208:190-197.
   PubMed     Abstract available
   
   
   
2. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
   Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
   Thromb Res. 2021;208:170-172.
   PubMed    
   
   
   
3. GIRAUD M, Catella J, Cognet L, Helfer H, et al
   Management of acute venous thromboembolism in patients taking antiplatelet therapy.
   Thromb Res. 2021;208:156-161.
   PubMed     Abstract available
   
   
   
4. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
   Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
   Thromb Res. 2021;208:106-111.
   PubMed     Abstract available
   
   
   
5. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
   Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
   Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
   PubMed    
   
   
   October 2021
6. LEE A, Oley F Jr, Lo M, Fong R, et al
   Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
   Thromb Res. 2021;208:148-155.
   PubMed     Abstract available
   
   
   
7. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
   Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
   Thromb Res. 2021;208:79-82.
   PubMed     Abstract available
   
   
   
8. HILL H, Robinson M, Lu L, Slaughter D, et al
   Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
   Thromb Res. 2021;208:71-78.
   PubMed     Abstract available
   
   
   
9. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
   Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
   Thromb Res. 2021;208:121-126.
   PubMed     Abstract available
   
   
   
10. LI A, Brandt W, Brown C, Wang TF, et al
    Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Thromb Res. 2021;208:58-65.
    PubMed     Abstract available
    
    
    
11. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
    Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
    Thromb Res. 2021;208:52-57.
    PubMed     Abstract available
    
    
    
12. LI J, Yi J, Hua L, Su Y, et al
    Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Thromb Res. 2021;208:45-51.
    PubMed     Abstract available
    
    
    
13. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
    Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
    Thromb Res. 2021;208:39-44.
    PubMed     Abstract available
    
    
    
14. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
    Thromb Res. 2021;208:4-10.
    PubMed     Abstract available
    
    
    
15. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
    Thromb Res. 2021;207:150-157.
    PubMed     Abstract available
    
    
    
16. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    PubMed     Abstract available
    
    
    September 2021
17. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
    Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Thromb Res. 2021;207:143-149.
    PubMed     Abstract available
    
    
    
18. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
    Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
    Thromb Res. 2021;207:113-115.
    PubMed    
    
    
    
19. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
    Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Thromb Res. 2021;207:116-122.
    PubMed     Abstract available
    
    
    
20. GABET A, Grave C, Tuppin P, Emmerich J, et al
    Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
    Thromb Res. 2021;207:67-74.
    PubMed     Abstract available
    
    
    
21. OAKES M, Arastu A, Kato C, Somers J, et al
    Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Thromb Res. 2021;207:96-98.
    PubMed     Abstract available
    
    
    August 2021
22. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
    Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
    Thromb Res. 2021;206:139-141.
    PubMed    
    
    
    
23. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
    Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
    Thromb Res. 2021;206:128-130.
    PubMed    
    
    
    
24. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
    Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
    Thromb Res. 2021;206:99-103.
    PubMed     Abstract available
    
    
    
25. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
    Pulmonary embolism and deep vein thrombosis: Similar but different.
    Thromb Res. 2021;206:88-98.
    PubMed     Abstract available
    
    
    
26. JOHNSON SA, Jones AE, Young E, Jennings C, et al
    A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Thromb Res. 2021;206:120-127.
    PubMed     Abstract available
    
    
    
27. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
    Media portrayals of pulmonary embolism.
    Thromb Res. 2021;206:52-54.
    PubMed    
    
    
    
28. FILIPPI L, Sartori M, Facci M, Trentin M, et al
    Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
    Thromb Res. 2021;206:29-32.
    PubMed     Abstract available
    
    
    
29. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
    Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
    Thromb Res. 2021;207:134-139.
    PubMed     Abstract available
    
    
    
30. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
    Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
    Thromb Res. 2021;204:114-122.
    PubMed     Abstract available
    
    
    July 2021
31. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
    Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Thromb Res. 2021;206:36-41.
    PubMed     Abstract available
    
    
    
32. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    PubMed     Abstract available
    
    
    
33. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    PubMed     Abstract available
    
    
    
34. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    PubMed    
    
    
    
35. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    PubMed     Abstract available
    
    
    
36. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    PubMed     Abstract available
    
    
    
37. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
    Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
    Thromb Res. 2021;206:1-4.
    PubMed    
    
    
    
38. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    PubMed    
    
    
    
39. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    PubMed     Abstract available
    
    
    June 2021
40. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    PubMed     Abstract available
    
    
    
41. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    PubMed     Abstract available
    
    
    
42. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    PubMed     Abstract available
    
    
    
43. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    PubMed     Abstract available
    
    
    
44. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    PubMed    
    
    
    
45. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    PubMed     Abstract available
    
    
    
46. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    PubMed     Abstract available
    
    
    
47. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    PubMed    
    
    
    
48. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    PubMed    
    
    
    May 2021
49. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    PubMed     Abstract available
    
    
    
50. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    PubMed    
    
    
    
51. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    PubMed     Abstract available
    
    
    
52. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    PubMed     Abstract available
    
    
    
53. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    PubMed     Abstract available
    
    
    
54. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    PubMed     Abstract available
    
    
    
55. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    PubMed     Abstract available
    
    
    
56. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    PubMed     Abstract available
    
    
    
57. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    PubMed    
    
    
    
58. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    PubMed     Abstract available
    
    
    
59. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    PubMed     Abstract available
    
    
    April 2021
60. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    PubMed     Abstract available
    
    
    
61. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    PubMed     Abstract available
    
    
    
62. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    PubMed    
    
    
    March 2021
63. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    PubMed     Abstract available
    
    
    
64. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    PubMed     Abstract available
    
    
    
65. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    PubMed    
    
    
    
66. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    PubMed     Abstract available
    
    
    
67. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    PubMed     Abstract available
    
    
    
68. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    PubMed    
    
    
    
69. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    PubMed    
    
    
    
70. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    PubMed     Abstract available
    
    
    
71. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    PubMed     Abstract available
    
    
    
72. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    PubMed     Abstract available
    
    
    
73. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    PubMed    
    
    
    
74. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    PubMed     Abstract available
    
    
    
75. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    PubMed     Abstract available
    
    
    
76. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    PubMed     Abstract available
    
    
    February 2021
77. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    PubMed    
    
    
    
78. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    PubMed     Abstract available
    
    
    
79. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    PubMed     Abstract available
    
    
    
80. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    PubMed     Abstract available
    
    
    
81. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    PubMed     Abstract available
    
    
    
82. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    PubMed    
    
    
    
83. 
    Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    PubMed    
    
    
    January 2021
84. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    PubMed    
    
    
    
85. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    PubMed     Abstract available
    
    
    
86. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    PubMed    
    
    
    
87. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    PubMed     Abstract available
    
    
    
88. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    PubMed    
    
    
    
89. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    PubMed     Abstract available
    
    
    
90. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    PubMed     Abstract available
    
    
    
91. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    PubMed    
    
    
    
92. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    PubMed    
    
    
    
93. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    PubMed     Abstract available
    
    
    
94. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    PubMed     Abstract available
    
    
    
95. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    PubMed    
    
    
    
96. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    PubMed     Abstract available
    
    
    December 2020
97. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    PubMed     Abstract available
    
    
    
98. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    PubMed     Abstract available
    
    
    
99. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    PubMed    
    
    
    
100. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
     Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
     Thromb Res. 2020;199:32-34.
     PubMed    
     
     
     
101. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
     Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
     Thromb Res. 2020;198:135-138.
     PubMed     Abstract available
     
     
     
102. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
     Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
     Thromb Res. 2020;198:163-170.
     PubMed     Abstract available
     
     
     
103. DE WIT K, Linkins LA
     A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
     Thromb Res. 2020;198:83-85.
     PubMed     Abstract available
     
     
     
104. MIAO R, Dong X, Gong J, Wang Y, et al
     Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
     Thromb Res. 2020;198:122-131.
     PubMed     Abstract available
     
     
     
105. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
     Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2020;198:103-114.
     PubMed     Abstract available
     
     
     
106. WANG L, Chen F, Bai L, Yi Q, et al
     In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
     Thromb Res. 2020;196:541-542.
     PubMed    
     
     
     
107. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
     COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
     Thromb Res. 2020;196:355-358.
     PubMed     Abstract available
     
     
     November 2020
108. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
     Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
     Thromb Res. 2020;198:26-33.
     PubMed     Abstract available
     
     
     
109. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
     Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
     Thromb Res. 2020;198:1-6.
     PubMed     Abstract available
     
     
     
110. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
     Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
     Thromb Res. 2020;198:52-54.
     PubMed    
     
     
     
111. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
     Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
     Thromb Res. 2020;198:34-39.
     PubMed     Abstract available
     
     
     
112. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
     D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
     Thromb Res. 2020;197:160-164.
     PubMed     Abstract available
     
     
     
113. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
     Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
     Thromb Res. 2020;197:144-152.
     PubMed     Abstract available
     
     
     
114. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
     Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
     Thromb Res. 2020;197:94-99.
     PubMed     Abstract available
     
     
     
115. ROBERGE G, Delluc A
     Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
     Thromb Res. 2020;197:77-83.
     PubMed     Abstract available
     
     
     
116. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
     Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
     Thromb Res. 2020;197:48-55.
     PubMed     Abstract available
     
     
     
117. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
     Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
     Thromb Res. 2020;197:8-12.
     PubMed     Abstract available
     
     
     
118. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
     The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
     Thromb Res. 2020;195:228-230.
     PubMed    
     
     
     
119. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
     Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
     Thromb Res. 2020;198:40-48.
     PubMed     Abstract available
     
     
     October 2020
120. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
     Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
     Thromb Res. 2020;196:539-540.
     PubMed    
     
     
     
121. SPEED V, Patel JP, Roberts LN, Patel RK, et al
     UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
     Thromb Res. 2020;197:16-19.
     PubMed    
     
     
     
122. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
     The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
     Thromb Res. 2020;196:486-490.
     PubMed     Abstract available
     
     
     
123. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
     Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
     Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
     PubMed    
     
     
     
124. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
     More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
     Thromb Res. 2020;196:435-436.
     PubMed    
     
     
     
125. HAN X, Li C, Zhang S, Hou X, et al
     Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
     Thromb Res. 2020;196:500-509.
     PubMed     Abstract available
     
     
     
126. VALERIO L, Corsi G, Sebastian T, Barco S, et al
     Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
     Thromb Res. 2020;196:494-499.
     PubMed     Abstract available
     
     
     
127. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
     Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
     Thromb Res. 2020;196:476-482.
     PubMed     Abstract available
     
     
     
128. GERSTEIN L, Koolian M, Schwartz BC
     Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
     Thromb Res. 2020;196:463-465.
     PubMed    
     
     
     
129. DOYLE AJ, Thomas W, Retter A, Besser M, et al
     Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
     Thromb Res. 2020;196:454-456.
     PubMed    
     
     
     
130. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
     Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
     Thromb Res. 2020;196:444-453.
     PubMed     Abstract available
     
     
     
131. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
     Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
     Thromb Res. 2020;194:220-221.
     PubMed    
     
     
     September 2020
132. YANG M, Qi J, Tang Y, Wu D, et al
     Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2020;196:410-413.
     PubMed    
     
     
     
133. MA SG, Hu J, Huang Y
     The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
     Thromb Res. 2020;196:325-334.
     PubMed     Abstract available
     
     
     
134. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
     D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
     Thromb Res. 2020;196:318-321.
     PubMed    
     
     
     
135. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
     High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
     Thromb Res. 2020;196:349-354.
     PubMed     Abstract available
     
     
     
136. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
     Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
     Thromb Res. 2020;196:308-312.
     PubMed     Abstract available
     
     
     
137. ROLVING N, Bloch-Nielsen JR, Brocki BC, Andreasen J, et al
     Perspectives of patients and health professionals on important factors influencing rehabilitation following acute pulmonary embolism: A multi-method study.
     Thromb Res. 2020;196:283-290.
     PubMed     Abstract available
     
     
     
138. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
     Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
     Thromb Res. 2020;196:313-317.
     PubMed     Abstract available
     
     
     
139. AGNELLI G, Hoffmann U, Hainaut P, Gaine S, et al
     ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
     Thromb Res. 2020;196:297-304.
     PubMed     Abstract available
     
     
     
140. DELATE T, Charlu M, Zhu S, Pai A, et al
     Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
     Thromb Res. 2020;196:367-370.
     PubMed     Abstract available
     
     
     
141. MIRO O, Llorens P, Aguirre A, Lozano L, et al
     Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
     Thromb Res. 2020;196:322-324.
     PubMed    
     
     
     
142. PIZZI R, Gini G, Caiano L, Castelli B, et al
     Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
     Thromb Res. 2020;196:209-212.
     PubMed     Abstract available
     
     
     
143. RAJENDRAM R, Kharal GA, Mahmood N, Kharal M, et al
     Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization.
     Thromb Res. 2020;196:206-208.
     PubMed     Abstract available
     
     
     August 2020
144. HANNEVIK TL, Brekke J, Enden T, Froen H, et al
     Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.
     Thromb Res. 2020;196:238-244.
     PubMed     Abstract available
     
     
     
145. BEENEN LFM, Bos LD, Scheerder MJ, Lobe NHJ, et al
     Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia.
     Thromb Res. 2020;196:135-137.
     PubMed    
     
     
     
146. ZERMATTEN MG, Pantet O, Gomez F, Schneider A, et al
     Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
     Thromb Res. 2020;196:222-226.
     PubMed    
     
     
     
147. SCHAEFER JK, Henke PK, Barnes GD
     Managing suspected venous thromboembolism when a pandemic limits diagnostic testing.
     Thromb Res. 2020;196:213-214.
     PubMed    
     
     
     
148. COELHO J, Divernet-Queriaud M, Roy PM, Penaloza A, et al
     Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65.
     Thromb Res. 2020;196:120-126.
     PubMed     Abstract available
     
     
     
149. JARVIS KB, Nielsen RL, Gupta R, Hede FD, et al
     Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
     Thromb Res. 2020;196:15-20.
     PubMed     Abstract available
     
     
     
150. PORFIDIA A, Valeriani E, Pola R, Porreca E, et al
     Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
     Thromb Res. 2020;196:67-74.
     PubMed     Abstract available
     
     
     
151. KUNUTSOR SK, Laukkanen JA
     Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.
     Thromb Res. 2020;196:27-30.
     PubMed    
     
     
     
152. FRIBERG L, Svennberg E
     A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.
     Thromb Res. 2020;195:238-242.
     PubMed     Abstract available
     
     
     
153. NOJIMA J, Kaneshige R, Motoki Y, Ieko M, et al
     Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome.
     Thromb Res. 2020;196:52-53.
     PubMed    
     
     
     
154. TSOLAKI V, Zakynthinos GE, Mantzarlis K
     Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients.
     Thromb Res. 2020;196:25-26.
     PubMed    
     
     
     July 2020
155. KOVACS MR, Lazo-Langner A, Louzada ML, Kovacs MJ, et al
     Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
     Thromb Res. 2020;195:231-232.
     PubMed    
     
     
     
156. HASSAN S, Fanola C, Beckman A, Li F, et al
     Adult Langerhans histiocytosis with rare BRAF mutation complicated by massive pulmonary embolism.
     Thromb Res. 2020;193:207-210.
     PubMed    
     
     
     
157. ALBERTSEN IE, Nielsen PB
     How to optimize the value of administrative venous thromboembolism codes.
     Thromb Res. 2020;194:195-196.
     PubMed    
     
     
     
158. NITHIANANDAN H, Reilly A, Tritschler T, Wells P, et al
     Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis.
     Thromb Res. 2020;195:195-208.
     PubMed     Abstract available
     
     
     
159. ZUIN M, Barco S, Zuliani G, Roncon L, et al
     Management of high-risk pulmonary embolism in an "unstable medical environment": Not only a matter of hemodynamic.
     Thromb Res. 2020;195:193-194.
     PubMed    
     
     
     
160. TRIMAILLE A, Curtiaud A, Marchandot B, Matsushita K, et al
     Venous thromboembolism in non-critically ill patients with COVID-19 infection.
     Thromb Res. 2020;193:166-169.
     PubMed    
     
     
     
161. PIAZZA G
     A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism.
     Thromb Res. 2020;195:169-170.
     PubMed    
     
     
     
162. EICHINGER S, Lin M, Shi M, Grosso MA, et al
     Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
     Thromb Res. 2020;195:209-214.
     PubMed     Abstract available
     
     
     
163. LECUMBERRI R, Ruiz-Artacho P, Trujillo-Santos J, Brenner B, et al
     Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
     Thromb Res. 2020;195:139-145.
     PubMed     Abstract available
     
     
     
164. WHYTE MB, Kelly PA, Gonzalez E, Arya R, et al
     Pulmonary embolism in hospitalised patients with COVID-19.
     Thromb Res. 2020;195:95-99.
     PubMed     Abstract available
     
     
     
165. GHANIMA W, Brodin E, Schultze A, Shepherd L, et al
     Incidence and prevalence of venous thromboembolism in Norway 2010-2017.
     Thromb Res. 2020;195:165-168.
     PubMed    
     
     
     
166. ANDREW L, Ni Ainle F, Blondon M, Rodger MA, et al
     Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality.
     Thromb Res. 2020;193:190-197.
     PubMed     Abstract available
     
     
     
167. PETERSEN PB, Jorgensen CC, Gromov K, Kehlet H, et al
     Venous thromboembolism after fast-track unicompartmental knee arthroplasty - A prospective multicentre cohort study of 3927 procedures.
     Thromb Res. 2020;195:81-86.
     PubMed     Abstract available
     
     
     
168. SCHWAB-DAUGHERTY EM, Peng MR, Caraccio EE, Stevens SM, et al
     Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism.
     Thromb Res. 2020;195:58-61.
     PubMed    
     
     
     
169. YURIDITSKY E, Mitchell OJL, Sista AK, Xia Y, et al
     Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism.
     Thromb Res. 2020;195:29-34.
     PubMed     Abstract available
     
     
     
170. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
     Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
     Thromb Res. 2020;191:148-150.
     PubMed     Abstract available
     
     
     
171. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
     Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
     Thromb Res. 2020;191:145-147.
     PubMed     Abstract available
     
     
     
172. MARAVEYAS A
     Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.
     Thromb Res. 2020;191 Suppl 1:S91-S98.
     PubMed     Abstract available
     
     
     
173. SANFILIPPO KM
     Assessing the risk of venous thromboembolism in multiple myeloma.
     Thromb Res. 2020;191 Suppl 1:S74-S78.
     PubMed     Abstract available
     
     
     
174. GEROTZIAFAS GT, Mahe I, Lefkou E, AboElnazar E, et al
     Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
     Thromb Res. 2020;191 Suppl 1:S50-S57.
     PubMed     Abstract available
     
     
     
175. ILICH A, Kumar V, Henderson M, Mallick R, et al
     Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study.
     Thromb Res. 2020;191 Suppl 1:S31-S36.
     PubMed     Abstract available
     
     
     
176. NOBLE S
     Venous thromboembolism in palliative care patients: what do we know?
     Thromb Res. 2020;191 Suppl 1:S128-S132.
     PubMed     Abstract available
     
     
     
177. VERSO M, Agnelli G
     Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life.
     Thromb Res. 2020;191 Suppl 1:S123-S127.
     PubMed     Abstract available
     
     
     June 2020
178. PREVITALI G, Seghezzi M, Moioli V, Sonzogni A, et al
     The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
     Thromb Res. 2020;194:192-194.
     PubMed    
     
     
     
179. NICHETTI F, Russo GL, Prelaj A, Provenzano L, et al
     ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
     Thromb Res. 2020;194:176-177.
     PubMed    
     
     
     
180. ZHANG GC, Zhang YY, Zeng QZ, Meng XY, et al
     Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
     Thromb Res. 2020;194:168-175.
     PubMed     Abstract available
     
     
     
181. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
     Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism.
     Thromb Res. 2020;193:160-165.
     PubMed     Abstract available
     
     
     
182. ROBIN P, van Es N, Le Roux PY, Rondina M, et al
     Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
     Thromb Res. 2020;194:153-157.
     PubMed     Abstract available
     
     
     
183. MAKHOUL T, Kelly G, Kersten B, Nadler M, et al
     Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
     Thromb Res. 2020;194:158-164.
     PubMed     Abstract available
     
     
     
184. OVERSTAD S, Tjonnfjord E, Garabet L, Fronas S, et al
     Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
     Thromb Res. 2020;194:116-118.
     PubMed    
     
     
     
185. HAYKAL T, Zayed Y, Deliwala S, Kerbage J, et al
     Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
     Thromb Res. 2020;194:57-65.
     PubMed     Abstract available
     
     
     
186. DEL-TORO-CERVERA J, Demelo-Rodriguez P, Galeano-Valle F, Fidalgo A, et al
     Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry.
     Thromb Res. 2020;194:178-182.
     PubMed     Abstract available
     
     
     
187. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
     Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?
     Thromb Res. 2020;193:86-89.
     PubMed     Abstract available
     
     
     
188. MURTHY SK, Robertson McCurdy AB, Carrier M, McCurdy JD, et al
     Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
     Thromb Res. 2020;194:26-32.
     PubMed     Abstract available
     
     
     
189. PICART G, Robin P, Tromeur C, Orione C, et al
     Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
     Thromb Res. 2020;194:1-7.
     PubMed     Abstract available
     
     
     
190. IBRAHIM-KOSTA M, Bailly P, Silvy M, Saut N, et al
     ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.
     Thromb Res. 2020;193:31-35.
     PubMed     Abstract available
     
     
     
191. VELASCO D, Jimenez D, Bikdeli B, Muriel A, et al
     Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders.
     Thromb Res. 2020;193:90-97.
     PubMed     Abstract available
     
     
     May 2020
192. HENDRIKS SV, Bavalia R, van Bemmel T, Bistervels IM, et al
     Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study.
     Thromb Res. 2020;193:60-65.
     PubMed     Abstract available
     
     
     
193. DESBOROUGH MJR, Doyle AJ, Griffiths A, Retter A, et al
     Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
     Thromb Res. 2020;193:1-4.
     PubMed    
     
     
     
194. PACKARD A, Delate T, Martinez K, Clark NP, et al
     Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service.
     Thromb Res. 2020;193:40-44.
     PubMed     Abstract available
     
     
     
195. CHEN X, Shao X, Zhang Y, Zhang Z, et al
     Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis.
     Thromb Res. 2020;193:99-106.
     PubMed     Abstract available
     
     
     
196. KONIECZYNSKA M, Kupis RW, Bijak P, Malinowski KP, et al
     Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters.
     Thromb Res. 2020;193:116-121.
     PubMed     Abstract available
     
     
     
197. AKEL T, Qaqa F, Abuarqoub A, Shamoon F, et al
     Pulmonary embolism: A complication of COVID 19 infection.
     Thromb Res. 2020;193:79-82.
     PubMed     Abstract available
     
     
     
198. PARRY AH, Wani AH
     Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management.
     Thromb Res. 2020 May 16. pii: S0049-3848(20)30194.
     PubMed    
     
     
     
199. GALEANO-VALLE F, Oblitas CM, Ferreiro-Mazon MM, Alonso-Munoz J, et al
     Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
     Thromb Res. 2020 May 15. pii: S0049-3848(20)30189.
     PubMed     Abstract available
     
     
     
200. RAHMANI J, Haghighian Roudsari A, Bawadi H, Thompson J, et al
     Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.
     Thromb Res. 2020;192:64-72.
     PubMed     Abstract available
     
     
     
201. ROSEN RJ
     Early thromboembolic events in hospitalized COVID-19 patients.
     Thromb Res. 2020;192:1.
     PubMed    
     
     
     
202. VITALI C, Minniti A, Caporali R, Del Papa N, et al
     Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19.
     Thromb Res. 2020;192:21-22.
     PubMed    
     
     
     
203. NISHIMOTO Y, Yamashita Y, Morimoto T, Saga S, et al
     Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
     Thromb Res. 2020;191:66-75.
     PubMed     Abstract available
     
     
     
204. BRUGGEMANN R, Gietema H, Jallah B, Ten Cate H, et al
     Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
     Thromb Res. 2020 May 1. pii: S0049-3848(20)30163.
     PubMed    
     
     
     April 2020
205. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
     Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
     Thromb Res. 2020;191:103-112.
     PubMed     Abstract available
     
     
     
206. LODIGIANI C, Iapichino G, Carenzo L, Cecconi M, et al
     Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
     Thromb Res. 2020;191:9-14.
     PubMed     Abstract available
     
     
     
207. ELLIS-KAHANA J, Sparks AD, Gimovsky AC, James AH, et al
     Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.
     Thromb Res. 2020;191:42-49.
     PubMed     Abstract available
     
     
     
208. JOHNSEN HS, Bjori E, Hindberg K, Braekkan SK, et al
     Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
     Thromb Res. 2020;191:82-89.
     PubMed     Abstract available
     
     
     
209. RONCON L, Zuin M, Zonzin P
     Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.
     Thromb Res. 2020;190:102.
     PubMed    
     
     
     
210. MARTINELLI I, Ferrazzi E, Ciavarella A, Erra R, et al
     Pulmonary embolism in a young pregnant woman with COVID-19.
     Thromb Res. 2020;191:36-37.
     PubMed    
     
     
     
211. FANG Q, Du W, Zhang X, Chen D, et al
     Venous thromboembolism and postoperative bleeding in thyroid surgery patients.
     Thromb Res. 2020;190:99-101.
     PubMed    
     
     
     
212. ROTZINGER DC, Beigelman-Aubry C, von Garnier C, Qanadli SD, et al
     Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.
     Thromb Res. 2020;190:58-59.
     PubMed     Abstract available
     
     
     March 2020
213. BOON GJAM, Barco S, Bertoletti L, Ghanima W, et al
     Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale.
     Thromb Res. 2020;190:45-51.
     PubMed     Abstract available
     
     
     
214. KELLER K, Hobohm L, Barco S, Schmidtmann I, et al
     Venous thromboembolism in patients hospitalized for hip joint replacement surgery.
     Thromb Res. 2020;190:1-7.
     PubMed     Abstract available
     
     
     
215. CHOI SH, Cha SI, Park JE, Park S, et al
     Electrocardiographic changes as a prognostic tool for hospitalized patients with pulmonary embolism.
     Thromb Res. 2020;192:61-63.
     PubMed    
     
     
     
216. RENZI M, Stafoggia M, Michelozzi P, Davoli M, et al
     Short-term exposure to PM2.5 and risk of venous thromboembolism: A case-crossover study.
     Thromb Res. 2020;190:52-57.
     PubMed     Abstract available
     
     
     
217. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
     Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
     Thromb Res. 2020 Mar 6. pii: S0049-3848(20)30069.
     PubMed    
     
     
     
218. HASAN RA, Koh AY, Zia A
     The gut microbiome and thromboembolism.
     Thromb Res. 2020;189:77-87.
     PubMed     Abstract available
     
     
     
219. BAUMGARTNER C, Go AS, Fan D, Sung SH, et al
     Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.
     Thromb Res. 2020;189:112-118.
     PubMed     Abstract available
     
     
     
220. LIANG S, Tang W, Ye S, Xiang L, et al
     Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
     Thromb Res. 2020;190:129-134.
     PubMed     Abstract available
     
     
     February 2020
221. DEGUCHI TK, Deguchi H, Guo Z, Elias DJ, et al
     Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.
     Thromb Res. 2020;189:88-92.
     PubMed     Abstract available
     
     
     
222. KUNUTSOR SK, Barrett MC, Whitehouse MR, Blom AW, et al
     Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: Meta-analyses of incidence, temporal trends and potential risk factors.
     Thromb Res. 2020;189:13-23.
     PubMed     Abstract available
     
     
     
223. BAVIERA M, Barcella L, Vannini T, Colacioppo P, et al
     Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
     Thromb Res. 2020;188:97-99.
     PubMed    
     
     
     
224. DANIELSBACKA JS, Hansson PO, Mannerkorpi K, Olsen MF, et al
     Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study.
     Thromb Res. 2020;189:55-60.
     PubMed     Abstract available
     
     
     
225. FULCHER J, Carrier M
     Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches?
     Thromb Res. 2020;188:100-102.
     PubMed     Abstract available
     
     
     
226. SCHMIDT RA, Al Zaki A, Desilet N, Szefer E, et al
     Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
     Thromb Res. 2020;188:106-114.
     PubMed     Abstract available
     
     
     January 2020
227. ROBIN P, Grewal RK, Le Roux PY, Le Gal G, et al
     Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism.
     Thromb Res. 2020;188:25-27.
     PubMed    
     
     
     
228. VAN ES J, Cheung YW, van Es N, Klok FA, et al
     Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
     Thromb Res. 2020;187:125-130.
     PubMed     Abstract available
     
     
     
229. CALAIS C, Mercier G, Meusy A, Le Collen L, et al
     Pulmonary embolism home treatment: What GP want?
     Thromb Res. 2020;187:180-185.
     PubMed     Abstract available
     
     
     
230. QUAN S, Smith J, Wu C, Koshman SL, et al
     Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism.
     Thromb Res. 2020;187:56-62.
     PubMed     Abstract available
     
     
     
231. TSUYUKI Y, Yamashita Y, Morimoto T, Amano H, et al
     Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
     Thromb Res. 2020;187:39-47.
     PubMed     Abstract available
     
     
     
232. GARVEY S, Dudzinski DM, Giordano N, Torrey J, et al
     Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes.
     Thromb Res. 2020;187:139-147.
     PubMed     Abstract available
     
     
     December 2019
233. BIKDELI B, Wang Y, Jimenez D, Ross JS, et al
     Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.
     Thromb Res. 2019;186:78-79.
     PubMed    
     
     
     
234. DOU F, Zhang Y, Yi J, Zhu M, et al
     Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.
     Thromb Res. 2019;186:36-41.
     PubMed     Abstract available
     
     
     
235. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
     "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
     Thromb Res. 2019;186:30-35.
     PubMed     Abstract available
     
     
     
236. FRENETTE A, Gershkovich B, Castellucci LA, Patel RV, et al
     Venous thromboembolism prophylaxis in obese, critically-ill patients: A survey of Ottawa region Intensivists.
     Thromb Res. 2019;186:42-44.
     PubMed    
     
     
     November 2019
237. MEDEIROS SK, Emery B, Bhagirath V, Parpia S, et al
     Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
     Thromb Res. 2019;186:13-19.
     PubMed     Abstract available
     
     
     
238. CANTOR N, Carrier M, Rodger MA, Veillet-Lemay G, et al
     Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study.
     Thromb Res. 2019;185:132-134.
     PubMed    
     
     
     
239. GARIANI K, Hugon-Rodin J, Philippe J, Righini M, et al
     Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2019;185:102-108.
     PubMed     Abstract available
     
     
     
240. BIKDELI B, Carrier MA, Bates SM
     Subsegmental pulmonary embolism: May not be a killer but indicates significant risk.
     Thromb Res. 2019 Nov 19. pii: S0049-3848(19)30504.
     PubMed    
     
     
     
241. TRUGILHO IA, Renni MJP, Medeiros GC, Thuler LCS, et al
     Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
     Thromb Res. 2019;185:49-54.
     PubMed     Abstract available
     
     
     
242. SIMONA A, Limacher A, Mean M, Golaz O, et al
     High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism.
     Thromb Res. 2019;185:5-12.
     PubMed     Abstract available
     
     
     
243. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
     Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
     Thromb Res. 2019;185:13-19.
     PubMed     Abstract available
     
     
     
244. JARVIS KB, LeBlanc M, Tulstrup M, Nielsen RL, et al
     Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
     Thromb Res. 2019;184:92-98.
     PubMed     Abstract available
     
     
     
245. SKAJAA N, Szepligeti SK, Horvath-Puho E, Ghanima W, et al
     Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
     Thromb Res. 2019;184:99-104.
     PubMed     Abstract available
     
     
     
246. HENDRIKS SV, Huisman MV, Eikenboom JCJ, Fogteloo J, et al
     Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.
     Thromb Res. 2019;184:122-128.
     PubMed     Abstract available
     
     
     
247. YAMASHITA Y, Murata K, Morimoto T, Amano H, et al
     Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
     Thromb Res. 2019;184:50-57.
     PubMed     Abstract available
     
     
     October 2019
248. KRIEG VJ, Hobohm L, Liebetrau C, Guth S, et al
     Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.
     Thromb Res. 2019;185:20-26.
     PubMed     Abstract available
     
     
     
249. BONNEFOY PB, Margelidon-Cozzolino V, Catella-Chatron J, Ayoub E, et al
     What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
     Thromb Res. 2019;184:67-76.
     PubMed     Abstract available
     
     
     
250. STOLLER N, Limacher A, Mean M, Baumgartner C, et al
     Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism.
     Thromb Res. 2019;184:24-30.
     PubMed     Abstract available
     
     
     
251. HEENKENDA MK, Malmstrom A, Lysiak M, Mudaisi M, et al
     Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
     Thromb Res. 2019;183:136-142.
     PubMed     Abstract available
     
     
     
252. DE WINTER MA, Remme GCP, Kaasjager KHAH, Nijkeuter M, et al
     Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' considerations.
     Thromb Res. 2019;183:49-55.
     PubMed     Abstract available
     
     
     
253. YU J, Li A, Laureano M, Crowther M, et al
     Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
     Thromb Res. 2019;184:16-23.
     PubMed     Abstract available
     
     
     
254. BYUN JM, Hong J, Yoon SS, Koh Y, et al
     Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
     Thromb Res. 2019;183:131-135.
     PubMed     Abstract available
     
     
     August 2019
255. RAJPURKAR M, Williams S, Goldenberg NA, Van Ommen CH, et al
     Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children.
     Thromb Res. 2019;183:98-105.
     PubMed     Abstract available
     
     
     May 2019
256. GILLESPIE C, Foley S, Rowan M, Ewins K, et al
     The OPTICA study (Optimised Computed Tomography Pulmonary Angiography in Pregnancy Quality and Safety study): Rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy.
     Thromb Res. 2019;177:172-179.
     PubMed     Abstract available
     
     
     
257. YAMASHITA Y, Morimoto T, Amano H, Takase T, et al
     Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
     Thromb Res. 2019;177:1-9.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: